SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors

NCT03604679 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SyB C-0501

Sponsor

SymBio Pharmaceuticals